{"id":"W4394823979","doi":"10.1097/ju9.0000000000000138","title":"Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2","year":2024,"lang":"en","type":"article","venue":"JU Open Plus","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Janssen Biotech; Foundation Medicine; National Cancer Institute; Cancer Center, University of Colorado; National Institutes of Health; Astellas Pharma; Daiichi-Sankyo; Invitae; National Center for Advancing Translational Sciences; Seagen; UroGen Pharma; Clovis Oncology; Sanofi; Exelixis; Advanced Accelerator Applications; Regeneron Pharmaceuticals; Prostate Cancer Foundation; Bristol-Myers Squibb; AstraZeneca; Myriad Genetics; Celgene; Amgen; Pfizer","keywords":"Prostate cancer; Medicine; Narrative review; Narrative; Oncology; Cancer; Management of prostate cancer; Gynecology; Internal medicine; Intensive care medicine; Art","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01955911,0.0009923852,0.001182159,0.004474612,0.001271549,0.004130042,0.001547378,0.004855468,0.006078237],"category_scores_gemma":[0.06298885,0.000591194,0.002305328,0.004301141,0.001493466,0.004955375,0.003086618,0.004417573,0.0009026075],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004581771,"about_ca_system_score_gemma":0.01374988,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003550655,"about_ca_topic_score_gemma":0.006678082,"domain_scores_codex":[0.9894057,0.00600741,0.001676337,0.0006720845,0.001721107,0.0005173029],"domain_scores_gemma":[0.9405748,0.04479762,0.004861536,0.0004890359,0.008173058,0.001104085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001804502,0.00004486572,0.000905905,0.1271815,0.0004660692,0.002008806,0.008131473,0.0006248223,0.0006760622,0.01687873,0.5880887,0.2548127],"study_design_scores_gemma":[0.00002743519,0.00004296506,0.0004580193,0.1213922,0.0004185795,0.001496583,0.003745317,0.00009688892,0.0002017277,0.002995697,0.8690678,0.00005694454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007836666,0.8830261,0.0006889311,0.1020763,0.008725266,0.0001735644,0.0003717012,0.00001974206,0.00413473],"genre_scores_gemma":[0.01603909,0.8925988,0.002045725,0.07556836,0.01085994,0.0005605976,0.0006555782,0.0000290442,0.001642944],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01955911,"threshold_uncertainty_score":0.1034396,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05177091720800439,"score_gpt":0.3919593903076974,"score_spread":0.340188473099693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}